Skip to main content

Advertisement

Log in

Oral Mucosal Melanoma: Some Pathobiological Considerations and an Illustrative Report of a Case

  • Case Report
  • Published:
Head and Neck Pathology Aims and scope Submit manuscript

Abstract

Oral mucosal melanoma is a relatively rare malignancy with an aggressive clinico-pathological behaviour. The mean 5-year survival rate is about 15 %. It arises primarily from melanocytes found in the basal cell layer of the epithelium, but may sometimes arise from melanocytes residing in the lamina propria. The pathogenesis is complex, and few of the molecular mechanisms underlying the development of oral mucosal melanoma have been defined. The extraneous risk factors associated with oral mucosal melanoma, if any, are unknown. Oral mucosal melanomas account for about 25 % of all mucosal melanomas of the head and neck, and exhibit a profile of cytogenetic alterations, and a pathobiological behaviour and clinical course different from that of cutaneous melanomas. As they are usually painless and grow quickly, as a rule, they are diagnosed late in the course of the disease when the lesions are already large and have metastasized to regional lymph nodes. In this paper we discuss some aspects of the pathobiology of oral mucosal melanoma, and present an illustrative case report.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  1. Pfister DG, Ang KK, Brizel DM, et al. Mucosal melanoma of the head and neck. JNCCN: J Natl Compr Cancer Netw. 2012;10:320–38.

    Google Scholar 

  2. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353:2135–47.

    Article  CAS  PubMed  Google Scholar 

  3. Postow MA, Hamid O, Carvajal RD. Mucosal melanoma: pathogenesis, clinical behavior, and management. Curr Oncol Rep. 2012;14:441–8.

    Article  CAS  PubMed  Google Scholar 

  4. Furney SJ, Turajlic S, Stamp G, et al. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013;230:261–9.

    Article  CAS  PubMed  Google Scholar 

  5. Wei C, Sirikanjanapong S, Lieberman S, et al. Primary mucosal melanoma arising from the eustachian tube with CTLA-4, IL-17A, IL-17C, and IL-17E upregulation. Ear Nose Throat J. 2013;92:36–40.

    PubMed Central  PubMed  Google Scholar 

  6. Papaspyrou G, Garbe C, Schadendorf D, et al. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res. 2011;21:475–82.

    Article  CAS  PubMed  Google Scholar 

  7. Kottschade LA, Grotz TE, Dronca RS, et al. Rare presentations of primary melanoma and special populations: a systematic review. Am J Clin Oncol. 2013. doi:10.1097/COC.0b013e3182868e82.

  8. Lourenco SV, Bologna SB, Hsieh R, et al. Establishment and characterization of an oral mucosal melanoma cell line (MEMO) derived from a longstanding primary oral melanoma. Am J Dermatopathol. 2013;35:248–51.

    Article  PubMed  Google Scholar 

  9. Wang X, Wu HM, Ren GX, et al. Primary oral mucosal melanoma: advocate a wait-and-see policy in the clinically N0 patient. J Oral Maxillofac Surg. 2012;70:1192–8.

    Article  PubMed  Google Scholar 

  10. Mohan M, Sukhadia VY, Pai D, et al. Oral malignant melanoma: systematic review of literature and report of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:e247–54.

    Article  PubMed  Google Scholar 

  11. Feller L, Masipa JN, Wood NH, et al. Primary oral melanoma associated with HIV infection. SADJ J S Afr Dent Assoc = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging. 2008;63:016–7.

    CAS  Google Scholar 

  12. Mihajlovic M, Vlajkovic S, Jovanovic P, et al. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5:739–53.

    PubMed Central  PubMed  Google Scholar 

  13. Gondivkar SM, Indurkar A, Degwekar S, et al. Primary oral malignant melanoma–a case report and review of the literature. Quintessence Int. 2009;40:41–6.

    PubMed  Google Scholar 

  14. Lucchese A, Favia G, Maiorano E, et al. Oral malignant melanoma: immunopathological analysis of a multiphasic case. Clin Exp Dermatol. 2010;35:789–91.

    Article  CAS  PubMed  Google Scholar 

  15. Shen ZY, Liu W, Bao ZX, et al. Oral melanotic macule and primary oral malignant melanoma: epidemiology, location involved, and clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:e21–5.

    Article  PubMed  Google Scholar 

  16. Shibuya H, Takeda M, Matsumoto S, et al. The efficacy of radiation therapy for a malignant melanoma in the mucosa of the upper jaw: an analytic study. Int J Radiat Oncol Biol Phys. 1993;25:35–59.

    Article  CAS  PubMed  Google Scholar 

  17. White RM, Zon LI. Melanocytes in development, regeneration, and cancer. Cell Stem Cell. 2008;3:242–52.

    Article  CAS  PubMed  Google Scholar 

  18. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008;128:2365–80.

    Article  CAS  PubMed  Google Scholar 

  19. Sober AJ, Tsao H, Washington CV. Cancer of the skin. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson LJ, Loscalzo J, editors. Harrisons principles of internal medicine. 17th ed. London: McGraw Hill Medical; 2008. p. 541–5.

    Google Scholar 

  20. Real C, Glavieux-Pardanaud C, Le Douarin NM, et al. Clonally cultured differentiated pigment cells can dedifferentiate and generate multipotent progenitors with self-renewing potential. Dev Biol. 2006;300:656–69.

    Article  CAS  PubMed  Google Scholar 

  21. Carcoforo P, Raiji MT, Palini GM, et al. Primary anorectal melanoma: an update. J Cancer. 2012;3:449–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Aubin-Houzelstein G, Djian-Zaouche J, Bernex F, et al. Melanoblasts’ proper location and timed differentiation depend on Notch/RBP-J signaling in postnatal hair follicles. J Invest Dermatol. 2008;128:2686–95.

    Article  CAS  PubMed  Google Scholar 

  23. Shah KV, Chien AJ, Yee C, et al. CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumors. J Invest Dermatol. 2008;128:2870–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Boland RP. The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol. 1974;5:409–29.

    Article  Google Scholar 

  25. Dupin E, Calloni G, Real C, et al. Neural crest progenitors and stem cells. CR Biol. 2007;330:521–9.

    Article  CAS  Google Scholar 

  26. Cramer SF. Stem cells for epidermal melanocytes–a challenge for students of dermatopathology. Am J Dermatopathol. 2009;31:331–41.

    Article  PubMed  Google Scholar 

  27. Keswel D, Davids LM, Kidson SH. Migration of human melanocytes into keratinocyte monolayers in vitro. J Dermatol Sci. 2012;66:160–3.

    Article  Google Scholar 

  28. Barrett AW, Scully C. Human oral mucosal melanocytes: a review. J Oral Pathol Med. 1994;23:97–103.

    Article  CAS  PubMed  Google Scholar 

  29. Wood NH, Khammissa R, Meyerov R, et al. Actinic cheilitis: a case report and a review of the literature. Eur J Dent. 2011;5:101–6.

    PubMed Central  PubMed  Google Scholar 

  30. Slominski A, Zbytek B, Slominski R. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer. 2009;124:1470–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Mackintosh JA. The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin. J Theor Biol. 2001;211:101–13.

    Article  CAS  PubMed  Google Scholar 

  32. Plonka PM, Passeron T, Brenner M, et al. What are melanocytes really doing all day long…? Exp Dermatol. 2009;18:799–819.

    Article  CAS  PubMed  Google Scholar 

  33. Slominski A, Wortsman J, Plonka PM, et al. Hair follicle pigmentation. J Invest Dermatol. 2005;124:13–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Slominski A. Neuroendocrine activity of the melanocyte. Exp Dermatol. 2009;18:760–3.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Carlson JA, Murphy M, Slominski A, et al. Evidence of skin field cancerization. In: Dakubo GD, editor. Field cancerization: basic science and clinical applications. Ontario: Nova Science Publishers; 2011. p. 317–70.

    Google Scholar 

  36. Bandarchi B, Jabbari CA, Vedadi A, et al. Molecular biology of normal melanocytes and melanoma cells. J Clin Pathol. 2013;66:644–8.

    Article  CAS  PubMed  Google Scholar 

  37. Hsieh R, Nico MM, Coutinho-Camillo CM, et al. The CDKN2A and MAP kinase pathways: molecular roads to primary oral mucosal melanoma. Am J Dermatopathol. 2013;35:167–75.

    Article  PubMed  Google Scholar 

  38. Vikey AK, Vikey D. Primary malignant melanoma, of head and neck: a comprehensive review of literature. Oral Oncol. 2012;48:399–403.

    Article  CAS  PubMed  Google Scholar 

  39. Wang E, Voiculescu S, Le Poole IC, et al. Clonal persistence and evolution during a decade of recurrent melanoma. J Investig Dermatol. 2006;126:1372–7.

    Article  CAS  PubMed  Google Scholar 

  40. Schatton T, Murphy GF, Frank NY, et al. Identification of cells initiating human melanomas. Nature. 2008;451:345–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Bologna SB, Nico MM, Hsieh R, et al. Adhesion molecules in primary oral mucosal melanoma: study of claudins, integrins and immunoglobulins in a series of 35 cases. Am J Dermatopathol. 2013;35:541–54.

    Article  PubMed  Google Scholar 

  42. Turri-Zanoni M, Medicina D, Lombardi D, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35:1066–77.

    Google Scholar 

  43. Hajar-Serviansky T, Gutierrez-Mendoza D, Galvan IL, et al. A case of oral mucosal melanoma. Clinical and dermoscopic correlation. J Dermatol Case Rep. 2012;6:1–4.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Barker BF, Carpenter WM, Daniels TE, et al. Oral mucosal melanomas: the WESTOP Banff workshop proceedings. Western Society of Teachers of Oral Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:672–9.

    Article  CAS  PubMed  Google Scholar 

  45. Murphy GF, Sellheyer K, Mihm MC. The skin. In: Kumar V, Abbas AK, Fausto N, editors. Pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2005. p. 1234–6.

    Google Scholar 

  46. Kerr EH, Hameed O, Lewis JS Jr, et al. Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. Int J Surg Pathol. 2012;20:37–46.

    Article  PubMed  Google Scholar 

  47. Prasad ML, Patel SG, Shah JP, et al. Prognostic significance of regulators of cell cycle and apoptosis, p16(INK4a), p53, and bcl-2 in primary mucosal melanomas of the head and neck. Head Neck Pathol. 2012;6:184–90.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Professor B. Kramer for her intellectual input and constructive comments.

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. Feller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tlholoe, M.M., Khammissa, R.A.G., Bouckaert, M. et al. Oral Mucosal Melanoma: Some Pathobiological Considerations and an Illustrative Report of a Case. Head and Neck Pathol 9, 127–134 (2015). https://doi.org/10.1007/s12105-014-0526-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12105-014-0526-8

Keywords

Navigation